Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice
Authors
Keywords
-
Journal
JOURNAL OF LIPID RESEARCH
Volume 61, Issue 3, Pages 365-375
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2019-12-17
DOI
10.1194/jlr.ra119000419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis
- (2019) Marianne G. Pouwer et al. Journal of Diabetes Research
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of dual lipid-lowering therapy in coronary atherosclerosis regression: Evidence from recent studies
- (2018) Felice Gragnano et al. ATHEROSCLEROSIS
- Regression of atherosclerosis
- (2018) Amy C. Burke et al. CURRENT OPINION IN LIPIDOLOGY
- The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
- (2018) Pratik B Sandesara et al. ENDOCRINE REVIEWS
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
- (2017) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies
- (2015) Maciej Banach et al. BMC Medicine
- Non-high-density lipoprotein cholesterol
- (2015) Rutger Verbeek et al. CURRENT OPINION IN LIPIDOLOGY
- Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials
- (2015) Susan Kühnast et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
- (2015) Viktoria Gusarova et al. JOURNAL OF LIPID RESEARCH
- A systematic review of the time course of atherosclerotic plaque regression
- (2014) Adam M. Noyes et al. ATHEROSCLEROSIS
- Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
- (2014) Wen-Qian Gao et al. BMC Cardiovascular Disorders
- Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
- (2014) S. Kuhnast et al. EUROPEAN HEART JOURNAL
- PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
- (2014) Brandon Ason et al. JOURNAL OF LIPID RESEARCH
- Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
- (2014) Susan Kühnast et al. JOURNAL OF LIPID RESEARCH
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
- (2014) A. J. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy
- (2013) R. Puri et al. EUROPEAN HEART JOURNAL
- Local proliferation dominates lesional macrophage accumulation in atherosclerosis
- (2013) Clinton S Robbins et al. NATURE MEDICINE
- Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
- (2013) Peter Libby NEW ENGLAND JOURNAL OF MEDICINE
- Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
- (2013) Susan Kühnast et al. PLoS One
- Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin
- (2011) Susan Kühnast et al. JOURNAL OF HYPERTENSION
- Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE*3-Leiden.CETP Mice
- (2010) Silvia Bijland et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome
- (2010) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The dual PPARα/γ agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice
- (2009) JWA Van Der Hoorn et al. BRITISH JOURNAL OF PHARMACOLOGY
- The High-Risk Thin-Cap Fibroatheroma
- (2009) Pedro R. Moreno Circulation-Cardiovascular Interventions
- Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice
- (2008) Christophe Combadière et al. CIRCULATION
- Atherosclerotic Plaque Stability—What Determines the Fate of a Plaque?
- (2008) Bente Halvorsen et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
- (2007) Willeke de Haan et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More